Q4 2024 Holdings
Filed 2025-02-14 | 99 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $3.6K | 166,666 | 0.0% |
| Revolution Medicines Inc(RVMDW) | *W EXP 12/17/202 | 76155X118 | $45.0K | 250,000 | 0.0% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $237.0K | 150,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $294.0K | 188,462 | 0.0% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $602.0K | 50,000 | 0.0% |
| Ensysce Biosciences Inc(ENSC) | COM NEW | 293602504 | $705.5K | 86,666 | 0.0% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $736.3K | 860,000 | 0.0% |
| Nanobiotix(NBTX) | SPONSORED ADS | 63009J107 | $763.7K | 266,093 | 0.0% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $804.0K | 100,000 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $920.1K | 139,835 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.1M | 238,000 | 0.0% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $1.5M | 164,157 | 0.0% |
| Trinity Biotech PLC(TRIB) | SPON ADR NEW | 896438504 | $1.6M | 1,790,000 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $1.8M | 500,000 | 0.0% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $2.2M | 95,742 | 0.1% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $2.3M | 3,249,669 | 0.1% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $2.6M | 12,757,562 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.8M | 197,108 | 0.1% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $3.1M | 1,221,734 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $3.1M | 829,536 | 0.1% |
| Athira Pharma Inc | COM | 04746L104 | $3.2M | 5,402,964 | 0.1% |
| Biodesix Inc | COM | 09075X108 | $3.3M | 2,173,880 | 0.1% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $3.6M | 7,236,843 | 0.1% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.8M | 1,190,263 | 0.1% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $3.8M | 1,085,512 | 0.1% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $4.2M | 6,483,157 | 0.1% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $4.7M | 180,546 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.8M | 378,584 | 0.1% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.3M | 500,000 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $5.5M | 311,551 | 0.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $5.9M | 65,153 | 0.2% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $6.1M | 744,035 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $6.2M | 330,614 | 0.2% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $8.6M | 1,004,439 | 0.2% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $9.1M | 178,797 | 0.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $9.2M | 1,078,495 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $9.3M | 5,880,000 | 0.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $9.4M | 184,525 | 0.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $9.9M | 144,000 | 0.3% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $10.3M | 9,812,419 | 0.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $10.3M | 186,662 | 0.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $10.7M | 145,000 | 0.3% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $11.5M | 1,537,274 | 0.3% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $11.9M | 2,140,000 | 0.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $12.0M | 419,450 | 0.3% |
| Merus N V | COM | N5749R100 | $12.6M | 300,000 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.8M | 325,324 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $12.8M | 543,277 | 0.4% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $13.7M | 100,050 | 0.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $14.2M | 740,749 | 0.4% |